Zurich Cantonal Bank’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$521K Sell
58,095
-121
-0.2% -$1.08K ﹤0.01% 1640
2025
Q1
$437K Sell
58,216
-30
-0.1% -$225 ﹤0.01% 1680
2024
Q4
$438K Buy
58,246
+7,234
+14% +$54.4K ﹤0.01% 1704
2024
Q3
$388K Buy
51,012
+3,653
+8% +$27.8K ﹤0.01% 1715
2024
Q2
$293K Hold
47,359
﹤0.01% 1837
2024
Q1
$241K Hold
47,359
﹤0.01% 1953
2023
Q4
$284K Buy
47,359
+10,086
+27% +$60.4K ﹤0.01% 1875
2023
Q3
$264K Sell
37,273
-2
-0% -$14 ﹤0.01% 1796
2023
Q2
$262K Buy
37,275
+8,945
+32% +$63K ﹤0.01% 1737
2023
Q1
$236K Buy
28,330
+1,663
+6% +$13.9K ﹤0.01% 1769
2022
Q4
$306K Buy
26,667
+1,345
+5% +$15.4K ﹤0.01% 1561
2022
Q3
$319K Hold
25,322
﹤0.01% 1471
2022
Q2
$268K Hold
25,322
﹤0.01% 1617
2022
Q1
$412K Sell
25,322
-5,225
-17% -$85K ﹤0.01% 1455
2021
Q4
$423K Buy
30,547
+3,715
+14% +$51.4K ﹤0.01% 1574
2021
Q3
$386K Buy
26,832
+66
+0.2% +$949 ﹤0.01% 1465
2021
Q2
$423K Buy
26,766
+2,413
+10% +$38.1K ﹤0.01% 1325
2021
Q1
$248K Buy
24,353
+564
+2% +$5.74K ﹤0.01% 1666
2020
Q4
$177K Hold
23,789
﹤0.01% 1924
2020
Q3
$82K Hold
23,789
﹤0.01% 2066
2020
Q2
$113K Buy
23,789
+6,229
+35% +$29.6K ﹤0.01% 1879
2020
Q1
$35K Buy
17,560
+11,392
+185% +$22.7K ﹤0.01% 2105
2019
Q4
$21K Hold
6,168
﹤0.01% 2488
2019
Q3
$18K Hold
6,168
﹤0.01% 2470
2019
Q2
$23K Hold
6,168
﹤0.01% 2428
2019
Q1
$50K Hold
6,168
﹤0.01% 2006
2018
Q4
$50K Hold
6,168
﹤0.01% 2026
2018
Q3
$47K Hold
6,168
﹤0.01% 2185
2018
Q2
$35K Hold
6,168
﹤0.01% 2296
2018
Q1
$29K Hold
6,168
﹤0.01% 2306
2017
Q4
$30K Buy
6,168
+4,367
+242% +$21.2K ﹤0.01% 2285
2017
Q3
$9K Hold
1,801
﹤0.01% 2430
2017
Q2
$10K Hold
1,801
﹤0.01% 2419
2017
Q1
$15K Hold
1,801
﹤0.01% 2388
2016
Q4
$11K Hold
1,801
﹤0.01% 2417
2016
Q3
$8K Hold
1,801
﹤0.01% 2447
2016
Q2
$5K Hold
1,801
﹤0.01% 2489
2016
Q1
$5K Hold
1,801
﹤0.01% 2497
2015
Q4
$19K Buy
1,801
+1,126
+167% +$11.9K ﹤0.01% 2112
2015
Q3
$8K Buy
+675
New +$8K ﹤0.01% 2194